Back to DNLI

Denali Therapeutics Inc. 8-K

Accession 0001193125-18-154519

Filing information

CIK
0001714899
Report date
2018-05-02
Filing date
2018-05-07
Form
8-K
Primary document
d551037d8k.htm

Open primary document

View the filing document on sec.gov.

Open EDGAR directory

Inspect all files for this filing.

Complete submission file

Open the raw SEC submission text.